| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $53.4B | $39.1B | $36.8B | $34.3B | $30.4B | $28.5B | $28.6B | $28.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $2.5B | $4.8B | $4.9B | $7.4B | $12.4B | $2.7B | $5.5B | $6.0B |
| EPS (Basic) | $4.03 | $11.61 | $11.98 | $17.98 | $27.04 | $5.19 | $11.10 | $11.90 |
| EPS (Diluted) | $4.03 | $11.59 | $11.95 | $17.91 | $26.94 | $5.18 | $11.05 | $11.82 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $669.0B | $490.1B | $478.5B | $455.2B | $432.4B | $421.6B | $390.4B | $372.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $555.4B | $429.4B | $420.4B | $402.7B | $371.4B | $361.4B | $332.4B | $320.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $113.6B | $60.8B | $58.1B | $52.6B | $61.0B | $60.2B | $58.0B | $51.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $27.7B | $18.2B | $20.6B | $13.8B | $12.3B | $16.7B | $16.6B | $13.0B |
| Investing Cash Flow | $-0.4B | $-26.4B | $-21.9B | $-29.7B | $-31.5B | $-14.8B | $-23.0B | $-15.6B |
| Capital Expenditures | $1.6B | $1.2B | $1.0B | $0.9B | $0.7B | $0.7B | $0.9B | $0.9B |
| Financing Cash Flow | $-8.9B | $8.2B | $13.8B | $25.1B | $0.5B | $25.2B | $6.6B | $1.8B |